First Clinical Publication in Japan for the SpineGuard DSG® Technology
16 Décembre 2019 - 8:00AM
Business Wire
Cervical screw guidance
Regulatory News:
SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative
company that deploys its DSG® (Dynamic Surgical Guidance) sensing
technology to secure and streamline the placement of bone implants,
announced today the first clinical publication in Japan for its DSG
technology.
This technical note published in Neurologia medico-chirurgica
(the official peer-reviewed scientific journal of the Japan
Neurosurgical Society) presents the clinical usefulness of
PediGuard for an optimal positioning of bi-cortical screws in the
lateral mass of the 1st cervical vertebra. These screws require an
extremely precise positioning in order to avoid the vertebral
artery as well as the internal carotid artery.
Link to publication abstract
Stéphane Bette, CEO of SpineGuard, said: “It is the first
scientific publication about our DSG technology in Japan, the 2nd
largest market worldwide in our sector1. Furthermore, in a
degenerative cervical spine application that requires extreme
precision and sensitivity to screw placement, a specialty for
Japanese surgeons due to the prevalence of such pathologies in this
country. We are thus very happy about this 15th peer-reviewed
journal publication documenting the clinical value of our DSG
Technology in Spine. It strengthens the solid base of clinical
evidence in support of our DSG technology that we are determined to
deploy throughout new and promising clinical applications. We are
actively working with the venture bank Healthios Capital Markets in
order to find significant industry partnerships and generate growth
and value for our shareholders.”
Dr. Hiroto Kageyama, Assistant Professor of neurosurgery at
Hyogo College of Medicine, Nishinomyia, Hyogo, Japon adds: “We
found the PediGuard device useful in our practice for the insertion
of C1 lateral mass screws because it is easy to detect the anterior
cortical wall of the Atlas on the basis of its auditory signal.
After measuring the actual probe length, the screw length can be
decided and the bicortical screwing can be performed safely and
tightly.”
About SpineGuard®
Founded in 2009 in France and the USA by Pierre Jérôme and
Stéphane Bette, SpineGuard is an innovative company deploying its
proprietary radiation-free real time sensing technology DSG®
(Dynamic Surgical Guidance) to secure and streamline the placement
of implants in the skeleton. SpineGuard designs, develops and
markets medical devices that have been used in over 75,000 surgical
procedures worldwide. Fifteen studies published in peer-reviewed
scientific journals have demonstrated the multiple benefits DSG®
offers to patients, surgeons, surgical staff and hospitals.
Building on these solid fundamentals and several strategic
partnerships, SpineGuard has expanded its technology platform in a
disruptive innovation: the « smart » pedicle screw launched late
2017 and is broadening the scope of applications in dental
implantology and surgical robotics. DSG® was co-invented by Maurice
Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem,
Biomedical Engineer.
For further information, visit www.spineguard.com
Disclaimer
The SpineGuard securities may not be offered or sold in the
United States as they have not been and will not be registered
under the Securities Act or any United States state securities
laws, and SpineGuard does not intend to make a public offer of its
securities in the United States. This is an announcement and not a
prospectus, and the information contained herein does and shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of the securities referred to herein in
the United States in which such offer, solicitation or sale would
be unlawful prior to registration or exemption from
registration.
1 Source: "Spinal Surgery Devices Market: Global Market
Analysis, Dynamics, Country Share, Trends, Competitor Analysis 2013
- 2017 and Forecast 2018 - 2025", Kenneth Research, Dec. 2019
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191215005013/en/
SpineGuard Stéphane Bette Chief Executive Officer Tel:
+33 (0)1 45 18 45 19 s.bette@spineguard.com
Manuel Lanfossi Chief Financial Officer
m.lanfossi@spineguard.com
Europe / NewCap Investor Relations & Financial
Communication Mathilde Bohin / Pierre Laurent Tel: +33 (0)1 44 71
94 94 spineguard@newcap.eu
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024